Analytical Method Equivalency: An Acceptable Analytical Practice

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2005
Volume 29
Issue 9

Participants in a 2003 PhRMA workshop present the industry’s current thinking on developing analytical method equivalency, including the importance of sample selection, acceptance criteria, data evaluation, and documentation.

External Link - article-178592.pdf

Articles in this issue
i1_t-179357-1408683578893.gif
Securing the Supply Chain With RFID
Applications of Poly(ethylene in Drug Delivery Systems: Part II
Analytical Method Equivalency: An Acceptable Analytical Practice
The Nation Needs a Comprehensive Pharmaceutical Engineering Education and Research System
September 2005
Pilots and Partnerships Move RFID Forward
Reshaping CMC Development Services
Wash. Rinse. Repeat
i2-179358-1408683576722.gif
Artificial Distinctions: Protein A Mimetic Ligands for Bioprocess Separations
i1-179351-1408683585762.jpg
Outsourcing Atrophy: A Cautionary Tale
In the Spotlight-September 2005
FDA Faces Multiple Challenges
Recent Videos
Lee Cronin, founder and CEO of Chemify
Related Content
Future and media concept | Image Credit: ©peshkova - stock.adobe.com

Integrating Advanced Technologies for Pharma Analysis

Cynthia A. Challener
December 8th 2024
Article

Automation technologies provide real potential to improve responsiveness and decision-making in drug development.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Abzena Expands Analytical Services with GMP Cell-Based Potency Testing in US and UK

Feliza Mirasol
November 22nd 2024
Article

The company has expanded its early and late phase analytical capabilities by including GMP cell-based potency assays at its sites in Cambridge, UK, and San Diego, Calif.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Three New European Facilities Established by BioPharmaSpec for R&D

Feliza Mirasol
November 21st 2024
Article

Located in German, Italy, and Lithuania, the new European facilities will specialize in drug discovery and R&D services.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Newly Opened Innovation Center in New Jersey Gives Avantor Advantage in Solving Life Sciences Challenges

Feliza Mirasol
November 15th 2024
Article

Avantor's newly launched expanded Innovation Center in Bridgewater, NJ, is designed for integrated workflows and features purpose-built collaboration spaces.

Two scientists wearing lab coats and safety glasses analyzing data displayed on a computer screen in a laboratory setting | Image Credit: © NCST Studio - © NCST Studio - stock.adobe.com

Untethered Data: Unifying and Contextualizing Drug Discovery Data

Chris Stumpf
November 5th 2024
Article

Capturing and curating R&D data are crucial to realizing the full value of advanced analytics.